A Seattle-based biotech company is turning heads on Wednesday morning after it was announced that the company received a US patent for its respiratory tract delivery of levodopa...

To read the full story on AllPennyStocks.com, click here.

Impel Pharmaceuticals (NASDAQ:IMPL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Impel Pharmaceuticals.
Impel Pharmaceuticals (NASDAQ:IMPL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Impel Pharmaceuticals.